Skip to content
  • Home
  • About Us
  • Services
  • Courses
  • Online Learning
  • News and Events
  • Contact Us
  • Home
  • About Us
  • Services
  • Courses
  • Online Learning
  • News and Events
  • Contact Us

Alladvice

  1. Home>
  2. News and Events>
  3. Alladvice
Read more about the article EMA positive opinion for new gene therapy to treat multiple myeloma

EMA positive opinion for new gene therapy to treat multiple myeloma

  • Post published:April 7, 2022

EMA has recommended granting a conditional marketing authorisation for Carvykti (ciltacabtagene autoleucel) and it is now pending for European Commission decision.Medicines for human use are eligible for conditional marketing authorisation if…

Continue ReadingEMA positive opinion for new gene therapy to treat multiple myeloma

Revio is a Regulatory Affairs Consultancy – Created to support biopharmaceutical companies and public institutions, working with Advanced Therapy Medicinal Products (ATMPs)

Facebook-f Twitter Pinterest Linkedin

About

Home

About Us

Services

News & Events

Contact Us

Contact

TELEPHONES

+34 656 659 636

EMAIL

regaffairs@reviopharma.com

Legal

Cookies Policy

Data Protection

Legal Notice

Privacy policy

Social Networks

Copyright © 2024 – All Right Reserved – Powered by: Headteam.marketing

×

Cart